Detalles de la búsqueda
1.
Radiomics and PD-L1 expression predict immunotherapy benefits in patients with head and neck squamous cell carcinoma.
Future Oncol
; : 1-10, 2024 May 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38861311
2.
Efficacy and safety of atezolizumab, in combination with etoposide and carboplatin regimen, in the first-line treatment of extensive-stage small-cell lung cancer: a single-center experience.
Cancer Immunol Immunother
; 71(5): 1093-1101, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-34568975
3.
Establishment and characterization of patient-derived xenografts as paraclinical models for head and neck cancer.
BMC Cancer
; 20(1): 316, 2020 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32293356
4.
Molecular mechanisms of resistance to CDK4/6 inhibitors in breast cancer: A review.
Int J Cancer
; 145(5): 1179-1188, 2019 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30478914
5.
Pharmacogenetic analysis of advanced non-small-cell lung cancer patients treated with first-line paclitaxel and carboplatin chemotherapy.
Pharmacogenet Genomics
; 26(3): 116-25, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26641474
6.
Bone alkaline phosphatase as a surrogate marker of bone metastasis in gastric cancer patients.
BMC Cancer
; 16: 385, 2016 07 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-27377907
7.
Clinical implications from a single-center study of colorectal adenocarcinoma in transplant recipients.
Oncology
; 88(4): 195-200, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25502286
8.
Effect of glycopyrrolate versus atropine coadministered with neostigmine for reversal of rocuronium on postoperative catheter-related bladder discomfort in patients undergoing transurethral resection of bladder tumor: a prospective randomized study.
J Anesth
; 29(6): 831-5, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26254585
9.
Path Less Traveled: Targeting Rare Driver Oncogenes in Non-Small-Cell Lung Cancer.
JCO Oncol Pract
; 20(1): 47-56, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37733983
10.
Successful Rechallenge of Trastuzumab Deruxtecan After Drug-Induced Interstitial Lung Disease in a NSCLC With HER2 Mutation: A Case Report.
JTO Clin Res Rep
; 5(2): 100628, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38298273
11.
Multiplex analysis for the identification of plasma protein biomarkers for predicting lung cancer immunotherapy response.
Ther Adv Med Oncol
; 16: 17588359241254218, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38779033
12.
Analysis of tumor mutational burden and mutational landscape comparing whole-exome sequencing and comprehensive genomic profiling in patients with resectable early-stage non-small-cell lung cancer.
Ther Adv Med Oncol
; 16: 17588359241240657, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38523846
13.
A Phase II Trial of Nintedanib in Patients with Metastatic or Recurrent Head and Neck Squamous Cell Carcinoma: In-Depth Analysis of Nintedanib Arm from the KCSG HN 15-16 TRIUMPH Trial.
Cancer Res Treat
; 56(1): 37-47, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37475136
14.
D3S-001, a KRAS G12C inhibitor with rapid target engagement kinetics, overcomes nucleotide cycling and demonstrates robust preclinical and clinical activities.
Cancer Discov
; 2024 May 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38717075
15.
Epidemiology and Outcomes of Non-Small Cell Lung Cancer in South Korea.
JAMA Netw Open
; 7(2): e2355331, 2024 Feb 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38334998
16.
CONTACT-01: A Randomized Phase III Trial of Atezolizumab + Cabozantinib Versus Docetaxel for Metastatic Non-Small Cell Lung Cancer After a Checkpoint Inhibitor and Chemotherapy.
J Clin Oncol
; : JCO2302166, 2024 Mar 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38552197
17.
Discovery of a Novel Potent EGFR Inhibitor Against EGFR Activating Mutations and On-Target Resistance in NSCLC.
Clin Cancer Res
; 30(8): 1582-1594, 2024 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38330145
18.
Successful expansion and cryopreservation of human natural killer cell line NK-92 for clinical manufacturing.
PLoS One
; 19(2): e0294857, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38394177
19.
Exploring aryl hydrocarbon receptor expression and distribution in the tumor microenvironment, with a focus on immune cells, in various solid cancer types.
Front Immunol
; 15: 1330228, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38680496
20.
CD81 and CD82 expressing tumor-infiltrating lymphocytes in the NSCLC tumor microenvironment play a crucial role in T-cell activation and cytokine production.
Front Immunol
; 15: 1336246, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38515751